Experts question industry-funded study showing benefits of Tamiflu

Meta-analysis shows it shortens symptom duration and curbs complication riskRelated items from OnMedicaDrug giant agrees to release all Tamiflu trial dataSpending watchdog criticises government over TamifluClinical confirmation of H7N9 virus resistance to TamifluTamiflu reduced risk of death in H1N1 influenza pandemicExperts call for Tamiflu use to be reviewed
Source: OnMedica Latest News - Category: UK Health Source Type: news